Gene mutation prostate screening study aims to save lives
NCT ID NCT00261456
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 32 times
Summary
This study looks at men aged 40-69 who have certain gene mutations (BRCA1, BRCA2, or mismatch repair) that raise their risk for prostate cancer. Researchers give annual PSA tests to see how often cancer is found compared to men without these mutations. The goal is to learn more about prostate cancer in these high-risk men and improve screening methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Genetics Unit, Royal Marsden Hospital
Sutton, Surrey, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.